Dann, E. J. (2026) “Response to Comment on: ‘Is it time to reduce the doxorubicin dosage in Hodgkin lymphoma therapy?’”, Haematologica. Pavia, Italy, 111(9), p. 3181. doi: 10.3324/haematol.2026.301249.